Amedeo Smart

Free Medical Literature Service

 

Amedeo

Venous Thrombosis
  Free Subscription

Articles published in
Thromb Res
    April 2024
  1. LOPEZ N, Zamora-Martinez C, Montoya-Rodes M, Gabara C, et al
    Comparison of inferior vena cava filter use and outcomes between cancer and non-cancer patients in a tertiary hospital.
    Thromb Res. 2024;236:136-143.
    >> Share

    March 2024
  2. MOKART D, Serre E, Bruneel F, Kouatchet A, et al
    Acute pulmonary embolism in cancer patients admitted to intensive care unit: Impact of anticoagulant treatment on 90-day mortality and risk factors, results of a multicentre retrospective study.
    Thromb Res. 2024;237:129-137.
    >> Share

  3. GUTIERREZ-GUISADO J, Calvo-Sotelo AE, Hernandez-Blasco L, Fidalgo A, et al
    Venous thromboembolism (VTE) developing after ankle sprain. Comparison with VTE after knee arthroplasty.
    Thromb Res. 2024;237:94-99.
    >> Share

  4. BAASTRUP NN, Buch AK, Gundestrup AK, Olsen ASF, et al
    The incidence of venous thromboembolism after curative colon cancer surgery within an enhanced recovery after surgery programme.
    Thromb Res. 2024;237:46-51.
    >> Share

  5. LUTFI A, O'Rourke E, Crowley M, Craig E, et al
    VTE risk assessment, prevention and diagnosis in pregnancy.
    Thromb Res. 2024;235:164-174.
    >> Share

    February 2024
  6. OGIHARA Y, Yamashita Y, Morimoto T, Chatani R, et al
    Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2.
    Thromb Res. 2024;236:191-200.
    >> Share

  7. FLYNN C, Baldassarra J, Hamidi A
    Enoxaparin is safe for the treatment of venous thromboembolisms in patients with renal dysfunction: A retrospective cohort study.
    Thromb Res. 2024;236:127-129.
    >> Share

  8. RAJPURKAR M, Rosovsky RP, Williams S, Chan AKC, et al
    Considerations for instituting pediatric pulmonary embolism response teams: A tool kit.
    Thromb Res. 2024;236:97-107.
    >> Share

  9. BHANGU G, Murray A, Qayyum A, Goumeniouk N, et al
    Diagnostic strategies in postpartum individuals with suspected venous thromboembolism: A scoping review.
    Thromb Res. 2024;236:108-116.
    >> Share

  10. SIMARD C, Poirier-Blanchette L, Rizzolo A, Cafaro T, et al
    Standardized direct oral anticoagulants prescription for treatment of acute venous thromboembolism in the emergency department: A quality improvement initiative.
    Thromb Res. 2024;236:68-73.
    >> Share

  11. BAO L, Fang LJ, Xiao MY, Lu MQ, et al
    Validation of the IMPEDE VTE score for prediction of venous thromboembolism in Chinese patients with multiple myeloma: A single-center retrospective cohort study.
    Thromb Res. 2024;236:130-135.
    >> Share

  12. VAN OMMEN CH, Luijnenburg SE
    Anticoagulation of pediatric patients with venous thromboembolism in 2023.
    Thromb Res. 2024 Feb 10:S0049-3848(24)00032.
    >> Share

    January 2024
  13. FAN Z, Xu S, Deng Y, Wei L, et al
    Disordered gut microbiota and alterations in the serum metabolome are associated with venous thromboembolism.
    Thromb Res. 2024;235:68-74.
    >> Share

  14. CHAIBI S, Roy PM, Guenegou AA, Tran Y, et al
    Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial.
    Thromb Res. 2024;235:79-87.
    >> Share

  15. YOO J, Jeon J, Baik M, Kim J, et al
    Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study.
    Thromb Res. 2024;235:32-40.
    >> Share

  16. CHOPARD R, Bertoletti L, Piazza G, Jimenez D, et al
    External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry.
    Thromb Res. 2024;235:22-31.
    >> Share

  17. ABDULREHMAN J, Harrigan A, Simard C, Tagalakis V, et al
    TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey.
    Thromb Res. 2024;235:11-14.
    >> Share

  18. ABRAHAO R, Brunson A, Chubak J, Wernli KJ, et al
    Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.
    Thromb Res. 2024;235:1-7.
    >> Share

  19. CASPERSEN CK, Ingemann-Molden S, Grove EL, Hojen AA, et al
    Performance-based outcome measures for assessing physical capacity in patients with pulmonary embolism: A scoping review.
    Thromb Res. 2024;235:52-67.
    >> Share

  20. TIRATRAKOONSEREE T, Charoenpichitnun S, Natesirinilkul R, Songthawee N, et al
    Clinical prediction tool to identify children at risk of pulmonary embolism.
    Thromb Res. 2024;234:151-157.
    >> Share

  21. HOUGHTON DE, Casanegra AI, Wysokinski WE, Padrnos LJ, et al
    COVID-19 infection and risk stratification for pulmonary embolism: Identifying optimal D-dimer thresholds.
    Thromb Res. 2024;235:8-10.
    >> Share

  22. YAN AR, Samarawickrema I, Naunton M, Peterson GM, et al
    Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
    Thromb Res. 2024;234:120-133.
    >> Share

  23. CHATANI R, Yamashita Y, Morimoto T, Mushiake K, et al
    Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2.
    Thromb Res. 2024;234:86-93.
    >> Share

    December 2023
  24. OBRADOVIC S, Dzudovic B, Simpson T, Matijasevic J, et al
    S wave resolution in lead aVL at 48 hours after pulmonary embolism admission predicts lower mortality.
    Thromb Res. 2023;234:36-38.
    >> Share

  25. GUMAN NAM, Kaptein FHJ, Lohle SB, Mairuhu ATA, et al
    Discharge from the emergency department and outpatient clinic in cancer patients with acute symptomatic and incidental pulmonary embolism: A multicenter retrospective cohort study.
    Thromb Res. 2023;233:181-188.
    >> Share

  26. PUCHADES R, Tung-Chen Y, Salgueiro G, Lorenzo A, et al
    Artificial intelligence for predicting pulmonary embolism: A review of machine learning approaches and performance evaluation.
    Thromb Res. 2023;234:9-11.
    >> Share

  27. RUEDA-CAMINO JA, Barba R, Otalora S, Bura-Riviere A, et al
    Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism.
    Thromb Res. 2023;233:165-172.
    >> Share

  28. FRENZEL L, Decaux O, Macro M, Belhadj-Merzoug K, et al
    Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group.
    Thromb Res. 2023;233:153-164.
    >> Share

  29. TRITSCHLER T, Sadeghipour P, Bikdeli B
    Subgroup analysis in randomized controlled trials: Useful or misleading?
    Thromb Res. 2023;232:160-162.
    >> Share

    November 2023
  30. LIPPI G, Mattiuzzi C, Favaloro EJ
    Recent monthly mortality for pulmonary embolism in the US.
    Thromb Res. 2023;233:99-100.
    >> Share

  31. INGEMANN-MOLDEN S, Caspersen CK, Rolving N, Hojen AA, et al
    Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review.
    Thromb Res. 2023;233:69-81.
    >> Share

  32. NAJARRO M, Briceno W, Rodriguez C, Muriel A, et al
    Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism.
    Thromb Res. 2023;233:18-24.
    >> Share

  33. APARICIO I, Iranzo P, Reyes R, Bote H, et al
    Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
    Thromb Res. 2023;232:133-137.
    >> Share

  34. CHEN AC, Rao AS, Oropallo A, Goldhaber SZ, et al
    Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
    Thromb Res. 2023;232:123-132.
    >> Share

  35. HEERINK JS, Oudega R, Gemen E, Hopstaken R, et al
    Are the latest point-of-care D-dimer devices ready for use in general practice? A prospective clinical evaluation of five test systems with a capillary blood feature for suspected venous thromboembolism.
    Thromb Res. 2023;232:113-122.
    >> Share

  36. ZABCZYK M, Kruk A, Natorska J, Undas A, et al
    Low-grade endotoxemia in acute pulmonary embolism: Links with prothrombotic plasma fibrin clot phenotype.
    Thromb Res. 2023;232:70-76.
    >> Share

  37. BIKDELI B, Piazza G
    The CORONA-VTE network registry: Revisiting the realities while encouraging enthusiasm.
    Thromb Res. 2023;231:7.
    >> Share

    October 2023
  38. PAREDES D, Del Carmen Diaz-Pedroche M, Gomez-Cuervo C, Perez-Jacoiste A, et al
    Identifying patients with prostate cancer at increased risk for haematuria during anticoagulation for venous thromboembolism.
    Thromb Res. 2023;232:54-61.
    >> Share

  39. KAPTEIJN MY, Lanting VR, Kaptein FHJ, Guman NAM, et al
    RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study.
    Thromb Res. 2023;232:27-34.
    >> Share

  40. TSUJISAKA Y, Yamashita Y, Morimoto T, Takase T, et al
    Application of the RIETE score to identify low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.
    Thromb Res. 2023;232:35-42.
    >> Share

  41. ISHISAKA Y, Watanabe A, Takagi H, Steiger D, et al
    Anticoagulation in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
    Thromb Res. 2023;231:91-98.
    >> Share

  42. YHIM HY, Lee J, Kim KH, Kim SA, et al
    Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea.
    Thromb Res. 2023;231:50-57.
    >> Share

    September 2023
  43. MAVROMANOLI AC, Jimenez D, Sanchez O, Sobkowicz B, et al
    Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis.
    Thromb Res. 2023;231:29-31.
    >> Share

  44. RAMBAUD G, Mai V, Motreff C, Sanchez O, et al
    Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.
    Thromb Res. 2023;231:58-64.
    >> Share

  45. XU Y, Khan F, Kovacs MJ, Sabri E, et al
    Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study.
    Thromb Res. 2023;231:32-38.
    >> Share

  46. DRAGSBAEK SJ, Lyhne MD, Hansen JV, Pedersen CCE, et al
    A porcine model of human-like chronic thromboembolic pulmonary disease.
    Thromb Res. 2023;231:25-28.
    >> Share

  47. STALS MAM, Beenen LFM, Coppens M, Faber LM, et al
    Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study.
    Thromb Res. 2023;231:65-75.
    >> Share

  48. AVERY J, Guffey D, Ma S, Basom R, et al
    Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Thromb Res. 2023;229:1-6.
    >> Share

    August 2023
  49. CHU G, Seelig J, Cannegieter SC, Gelderblom H, et al
    Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation.
    Thromb Res. 2023;230:98-104.
    >> Share

  50. SCOTT DM, Abud A, Amor M, Saemi A, et al
    Natural Language Processing tool accurately identifies acute venous thromboembolism.
    Thromb Res. 2023;229:252-254.
    >> Share

  51. FELIX G, Ferreira E, Ribeiro A, Guerreiro I, et al
    Predictors of cancer in patients with acute pulmonary embolism.
    Thromb Res. 2023;230:11-17.
    >> Share

    July 2023
  52. MEYER HJ, Gottschling S, Bar C, Wienke A, et al
    CT coronary calcium score is a prognostic marker in acute pulmonary embolism.
    Thromb Res. 2023;229:255-257.
    >> Share

  53. BENZIDIA I, Robitaille C, Abualsaud A, McDonald L, et al
    Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2023;229:139-145.
    >> Share

  54. ANIJS RJS, Chen Q, van der Hulle T, Versteeg HH, et al
    Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.
    Thromb Res. 2023;229:90-98.
    >> Share

  55. ALMAJDI A, Almutairi S, Alharbi M
    Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis.
    Thromb Res. 2023;229:77-85.
    >> Share

  56. HYDER SN, Han HB, Ash S, Horne BD, et al
    Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers.
    Thromb Res. 2023;227:45-50.
    >> Share

    June 2023
  57. LOWE G, Wu O, van Hylckama Vlieg A, Folsom A, et al
    Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic review and meta-analysis.
    Thromb Res. 2023;229:31-39.
    >> Share

  58. FILIPPI L, Turcato G, Milan M, Barbar S, et al
    Long term follow-up of a multicentre cohort of COVID-19 patients with pulmonary embolism: Anticoagulation management and outcomes.
    Thromb Res. 2023;229:73-76.
    >> Share

  59. JERVAN O, Dhayyat A, Gleditsch J, Haukeland-Parker S, et al
    Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism.
    Thromb Res. 2023;229:7-14.
    >> Share

  60. MUNOZ AJ, Souto JC, Lecumberri R, Obispo B, et al
    Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.
    Thromb Res. 2023;228:181-188.
    >> Share

  61. JAOUEN S, Mingant F, Lippert E, Galinat H, et al
    Using an age and fibrinogen levels adjusted D-dimer cutoff significantly improves the specificity of two equivalent D-dimer assays for excluding pulmonary embolism.
    Thromb Res. 2023;228:191-199.
    >> Share

  62. ZUIN M, Bikdeli B, Davies J, Krishnathasan D, et al
    Contemporary trends in mortality related to high-risk pulmonary embolism in US from 1999 to 2019.
    Thromb Res. 2023;228:72-80.
    >> Share

  63. BROWN C, Brandt W, Wang TF, Delluc A, et al
    Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis.
    Thromb Res. 2023;228:81-84.
    >> Share

    May 2023
  64. OTERO R, Lobo JL, Lopez R, Fernandez C, et al
    Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study.
    Thromb Res. 2023;228:1-9.
    >> Share

  65. ADDA-REZIG I, Cossu J, Falvo N, Ecarnot F, et al
    Home treatment versus early discharge for the outpatient management of acute pulmonary embolism: A non-interventional, post-hoc cohort analysis.
    Thromb Res. 2023;227:25-33.
    >> Share

  66. PALLARES ROBLES A, Ten Cate V, Lenz M, Schulz A, et al
    Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification.
    Thromb Res. 2023 May 8:S0049-3848(23)00124.
    >> Share

    April 2023
  67. LI HY, Wang J, Wang T, Wang HS, et al
    Management of venous thromboembolism in pediatric patients: Quality assessment of clinical practice guidelines and variations in recommendations.
    Thromb Res. 2023;226:107-116.
    >> Share

  68. CHIU J, Lazo-Langner A
    Venous thromboembolism in hematopoietic stem cell transplantation: A narrative review.
    Thromb Res. 2023;226:141-149.
    >> Share

  69. DROPPA M, Zdanyte M, Henes JK, Gawaz M, et al
    Continuous low-dose thrombolysis in patients with intermediate-high risk pulmonary embolism: A retrospective analysis.
    Thromb Res. 2023;226:33-35.
    >> Share

  70. KAPTEIN FHJ, Kroft LJM, van Dam LF, Stoger JL, et al
    Impact of pulmonary infarction in pulmonary embolism on presentation and outcomes.
    Thromb Res. 2023;226:51-55.
    >> Share

  71. KELLER K, Kohring C, Farmakis IT, Valerio L, et al
    Impact of venous thromboembolism on incidence of arterial thromboembolism - An analysis of German outpatient claims data.
    Thromb Res. 2023;226:9-17.
    >> Share

  72. QIAO N, Zhang Q, Chen L, He W, et al
    Machine learning prediction of venous thromboembolism after surgeries of major sellar region tumors.
    Thromb Res. 2023;226:1-8.
    >> Share

  73. COHEN A, Noxon V, Dhamane A, Bruette R, et al
    Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer.
    Thromb Res. 2023;226:117-126.
    >> Share

    March 2023
  74. ZBINDEN S, Voci D, Grigorean A, Holy EW, et al
    Clinical outcomes of ultrasound-assisted coagulation monitoring-adjusted catheter-directed thrombolysis for acute pulmonary embolism.
    Thromb Res. 2023;225:73-78.
    >> Share

  75. MATUSOV Y, Yaqoob M, Karumanchi A, Lipshutz HG, et al
    Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli.
    Thromb Res. 2023;225:57-62.
    >> Share

  76. KRECAK I, Grohovac D, Vucenovic Basic N, Ceko M, et al
    Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms.
    Thromb Res. 2023 Mar 21:S0049-3848(23)00078.
    >> Share

  77. ABDELHAY A, Mahmoud AA, Mostafa M, Al Ali O, et al
    Acute venous thromboembolic events in patients with monoclonal gammopathy of undetermined significance: An analysis of the National Inpatient Sample.
    Thromb Res. 2023;225:28-32.
    >> Share

    February 2023
  78. WIKLUND P, Medson K, Elf J
    Unreported incidental pulmonary embolism in patients with cancer: Radiologic natural history and risk of recurrent venous thromboembolism and death.
    Thromb Res. 2023;224:65-72.
    >> Share

  79. PRANDONI P, Bilora F, Mahe I, Varona JF, et al
    The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry.
    Thromb Res. 2023;224:17-20.
    >> Share

  80. ROHATGI N, Dahlen A, Berube C, Weng Y, et al
    Characteristics associated with diagnostic yield of imaging for deep venous thrombosis and pulmonary embolism in the emergency department, hospital, and office settings: An Optum Clinformatics claims database study (2015-2019).
    Thromb Res. 2023;224:4-12.
    >> Share

  81. ZHANG C, Deng Z, Yang Z, Xie J, et al
    A nomogram model to predict the acute venous thromboembolism risk after surgery in patients with glioma.
    Thromb Res. 2023;224:21-31.
    >> Share

  82. VOSTATEK R, Hohensinner P, Nopp S, Haider P, et al
    Association of telomere length and mitochondrial DNA copy number, two biomarkers of biological aging, with the risk of venous thromboembolism.
    Thromb Res. 2023;223:168-173.
    >> Share

    January 2023
  83. MIRAMBEAUX R, Rodriguez C, Muriel A, Gonzalez S, et al
    Comparison of various prognostic scores for identification of patients with intermediate-high risk pulmonary embolism.
    Thromb Res. 2023;223:61-68.
    >> Share

  84. ANDO K, Natsumeda M, Kawamura M, Shirakawa K, et al
    Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.
    Thromb Res. 2023;223:36-43.
    >> Share

  85. CIRES-DROUET R, LaRocco A, Soldin D, John T, et al
    Left ventricular systolic dysfunction during acute pulmonary embolism.
    Thromb Res. 2023;223:1-6.
    >> Share

  86. OGUNSOLA AS, Farhadi K, Mercy UC, Elenwa F, et al
    Analysis of contemporary mortality trends in pulmonary embolism, United States, 1999-2020.
    Thromb Res. 2023;223:53-60.
    >> Share

  87. KONG J, Hardwick A, Jiang SF, Sun K, et al
    CTEPH: A Kaiser Permanente Northern California Experience.
    Thromb Res. 2023;221:130-136.
    >> Share

  88. ZHENG C, Ma J, Xu J, Wu L, et al
    The optimal regimen, efficacy and safety of tranexamic acid and aminocaproic acid to reduce bleeding for patients after total hip arthroplasty: A systematic review and Bayesian network meta-analysis.
    Thromb Res. 2023;221:120-129.
    >> Share

    December 2022
  89. CHOPARD R, Campia U, Jering KS, Almarzooq ZI, et al
    Guideline adherence and clinical outcomes of patients with acute pulmonary embolism evaluated by a multidisciplinary response team at a quaternary care center.
    Thromb Res. 2022;222:113-116.
    >> Share

  90. FISCHER S, Meisinger C, Linseisen J, Berghaus TM, et al
    Depression and anxiety up to two years after acute pulmonary embolism: Prevalence and predictors.
    Thromb Res. 2022;222:68-74.
    >> Share

  91. MAXIMILIANO CL, Jaime GC, Erika MH
    Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban.
    Thromb Res. 2022;222:43-48.
    >> Share

  92. YU JL, Lane M, Roach GD, Morrison SD, et al
    Perioperative venous thromboembolism risk considerations in the gender diverse patient - Should we consider more than just estrogen?
    Thromb Res. 2022;222:40-42.
    >> Share

  93. PRANDONI P, Gabara C, Bilora F, Aibar J, et al
    Age over 75 does not increase the risk of recurrent venous thromboembolism: Findings from the RIETE registry.
    Thromb Res. 2022;222:16-19.
    >> Share

  94. HASSAN E, Motwani J
    Real world experience of efficacy and safety of rivaroxaban in paediatric venous thromboembolism.
    Thromb Res. 2022;221:92-96.
    >> Share

    November 2022
  95. IDING AFJ, Kremers BMM, Nagy M, Robles AP, et al
    Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism.
    Thromb Res. 2022;221:58-64.
    >> Share

  96. ARDESHIRROUHANIFARD S, Ellenbogen MI, Segal JB, Streiff MB, et al
    Healthcare utilization differences between an apixaban-based and warfarin-based strategy for acute venous thromboembolism in patients with end-stage kidney disease.
    Thromb Res. 2022;221:45-50.
    >> Share

  97. ARDESHNA NS, Song M, Hyder SN, Grace KA, et al
    Effect of pulmonary embolism response team on advanced therapies administered: The University of Michigan experience.
    Thromb Res. 2022;221:73-78.
    >> Share

  98. TURPIE AGG, Farjat AE, Haas S, Ageno W, et al
    36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.
    Thromb Res. 2022;222:31-39.
    >> Share

  99. KAPTEIN FHJ, Stals MAM, Evenhuis RE, Gelderblom H, et al
    Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.
    Thromb Res. 2022;221:19-25.
    >> Share

  100. STEINER D, Nopp S, Weber B, Schlager O, et al
    The post-VTE functional status scale for assessment of functional limitations in patients with venous thromboembolism: Construct validity and responsiveness in a prospective cohort study.
    Thromb Res. 2022;221:1-6.
    >> Share

  101. KAPTEIJN MY, Kaptein FHJ, Stals MAM, Klaase EE, et al
    Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.
    Thromb Res. 2022;221:10-18.
    >> Share

  102. WYSOKINSKI WE, Houghton DE, Vlazny DT, Ashrani AA, et al
    Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism.
    Thromb Res. 2022;221:37-44.
    >> Share

  103. BJORNHART B, Kristiansen C, Asmussen J, Hansen KH, et al
    Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy.
    Thromb Res. 2022 Nov 5. pii: S0049-3848(22)00438.
    >> Share

    October 2022
  104. KNUEPPEL P, Bang SH, Troyer C, Barriga A, et al
    Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE).
    Thromb Res. 2022;220:91-96.
    >> Share

  105. SILVEY M, Nguyen ATH, Amankwah EK, McElwaine E, et al
    Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium.
    Thromb Res. 2022;220:116-120.
    >> Share

  106. WENGER N, Sebastian T, Beer JH, Mazzolai L, et al
    Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Thromb Res. 2022;220:65-71.
    >> Share

  107. BAIDILDINOVA G, Ten Cate V, Nagler M, Panova-Noeva M, et al
    Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism.
    Thromb Res. 2022;220:75-87.
    >> Share

  108. RODRIGUEZ-RAMALLO H, Baez-Gutierrez N, Abdel-Kader-Martin L, Otero-Candelera R, et al
    Subgroup analyses in venous thromboembolism trials reporting pharmacological interventions: A systematic review.
    Thromb Res. 2022 Oct 11. pii: S0049-3848(22)00405.
    >> Share

  109. MARTIN KA, Lyleroehr MJ, Cameron KA
    Barriers and facilitators to preventing venous thromboembolism in oncology practice.
    Thromb Res. 2022;220:21-23.
    >> Share

    September 2022
  110. GRIS JC, Bourguignon C, Bouvier S, Nouvellon E, et al
    Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes.
    Thromb Res. 2022;219:102-108.
    >> Share

  111. ALBLAS H, van Kan C, van Het Westeinde SC, Emmering J, et al
    Persistent dyspnea after acute pulmonary embolism is related to perfusion defects and lower long-term quality of life.
    Thromb Res. 2022;219:89-94.
    >> Share

  112. SPEKSNIJDER EM, Hessels LM, Muusses L, Buller HR, et al
    Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients.
    Thromb Res. 2022;219:109-111.
    >> Share

  113. KELLER K, Sivanathan V, Schmitt VH, Ostad MA, et al
    Incidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease.
    Thromb Res. 2022;219:77-85.
    >> Share

  114. LUI B, Wee B, Lai J, Khattak Z, et al
    A ten-year review of the impact of the transition from warfarin to direct oral anticoagulant - Has venous thromboembolism treatment become safer?
    Thromb Res. 2022;219:112-120.
    >> Share

  115. YAMASHITA Y, Morimoto T, Kadota K, Takase T, et al
    Causes of long-term mortality in patients with venous thromboembolism in the real world: From the COMMAND VTE registry.
    Thromb Res. 2022;219:30-39.
    >> Share

  116. SONNE-HOLM E, Kjaergaard J, Bang LE, Kober L, et al
    Educational differences in mortality but not in risk of recurrence following first-time pulmonary embolism: A Danish nationwide register-based study.
    Thromb Res. 2022;219:22-29.
    >> Share

  117. LOW SK, Anjum Z, Mahmoud A, Joshi U, et al
    Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.
    Thromb Res. 2022;219:14-21.
    >> Share

  118. BORST JM, Modi RN, Kirchberg TN, Box K, et al
    You're never too old for optimal venous thromboembolism prophylaxis: Re-thinking current trauma guidelines.
    Thromb Res. 2022;218:186-188.
    >> Share

    August 2022
  119. VOIGTLAENDER M, Edler C, Gerling M, Schadler J, et al
    Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors.
    Thromb Res. 2022;218:171-176.
    >> Share

  120. PRANDONI P, Bilora F, Pesavento R, Sancho T, et al
    The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: Findings from the RIETE registry.
    Thromb Res. 2022;218:44-47.
    >> Share

  121. GORAN K
    Search for obtaining the highest net clinical benefit in pulmonary embolism patients: A new improvement considering the safety of thrombolysis.
    Thromb Res. 2022;218:5-7.
    >> Share

  122. MESSI M, Beneyto Afonso C, Stalder O, Mean M, et al
    Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment.
    Thromb Res. 2022;218:64-71.
    >> Share

  123. WANG WD, Wei JP, Gao RQ, Yang QC, et al
    A retrospective study of the role of preoperative ultrasonography in the detection of deep vein thrombosis in 1750 patients with gastric and colorectal cancers.
    Thromb Res. 2022;216:52-58.
    >> Share

  124. WIEGERS HMG, Scheres LJJ, Tahir L, Hutten BA, et al
    Risk of venous thromboembolism in women with endometriosis.
    Thromb Res. 2022;217:104-106.
    >> Share

    July 2022
  125. ATA F, Ibrahim WH, Choudry H, Shams A, et al
    Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis.
    Thromb Res. 2022;217:86-95.
    >> Share

  126. CHOI SH, Nguyen H, Kanjwal S, Ibrahim I, et al
    COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data.
    Thromb Res. 2022;217:60-63.
    >> Share

  127. MAHARAJ S, Chang S, Kloecker G, Chesney J, et al
    Venous and arterial thromboembolism with immunotherapy compared to platinum-based therapy.
    Thromb Res. 2022;217:48-51.
    >> Share

  128. ZUIN M, Rigatelli G, Bilato C, Bongarzoni A, et al
    Prognostic role of serial electrocardiographic changes in patients with acute pulmonary embolism. Data from the Italian Pulmonary Embolism Registry.
    Thromb Res. 2022;217:15-21.
    >> Share

  129. PANCANI R, Villari L, Aquilini F, Palla A, et al
    Prognostic role of respiratory failure in acute pulmonary embolism: a prospective multicenter study.
    Thromb Res. 2022;217:33-35.
    >> Share

  130. NAKANO Y, Adachi S, Nishiyama I, Yasuda K, et al
    Right ventricular pressure overload related to residual thrombotic burden in patients 1 year after acute pulmonary embolism: From the Nagoya PE study.
    Thromb Res. 2022;216:113-119.
    >> Share

    June 2022
  131. FANG MC, Go AS, Prasad PA, Zhou HX, et al
    Health-related quali ty of life associated with warfarin and direct oral anticoagulants in venous thromboembolism.
    Thromb Res. 2022;216:97-102.
    >> Share

  132. SHIBAHASHI E, Jujo K, Kuroda S, Matsumoto S, et al
    Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry.
    Thromb Res. 2022;216:90-96.
    >> Share

  133. VEETTIL SK, Harris J, Syeed MS, Thakkinstian A, et al
    Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review and meta-analysis.
    Thromb Res. 2022;216:74-83.
    >> Share

  134. SHEN J, Casie Chetty S, Shokouhi S, Maharjan J, et al
    Massive external validation of a machine learning algorithm to predict pulmonary embolism in hospitalized patients.
    Thromb Res. 2022;216:14-21.
    >> Share

  135. GUMAN NAM, van Haaps TF, van Es N, Leeflang MMG, et al
    Interrater agreement of two scales on the severity of anticoagulant-related major bleeding in patients with venous thromboembolism.
    Thromb Res. 2022;216:11-13.
    >> Share

    May 2022
  136. BRANDT W, Brown C, Wang TF, Tagalakis V, et al
    Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial.
    Thromb Res. 2022;216:8-10.
    >> Share

  137. SUBHANI M, Sheth A, Ahmed J, Wijayasiri P, et al
    Incidence and prevalence of venous thromboembolism in chronic liver disease: A systematic review and meta-analysis.
    Thromb Res. 2022;215:19-29.
    >> Share

  138. OBRADOVIC S, Subotic B, Dzudovic B, Matijasevic J, et al
    Pulmonary embolism bleeding score index (PEBSI): A new tool for the detection of patients with low risk for major bleeding on thrombolytic therapy.
    Thromb Res. 2022;214:138-143.
    >> Share

  139. BIKDELI B, Piazza G, Jimenez D, Muriel A, et al
    Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study.
    Thromb Res. 2022;214:122-131.
    >> Share

  140. ROSA V, Chaar CIO, Espitia O, Otalora S, et al
    A RIETE registry analysis of patients with upper extremity deep vein thrombosis and thoracic outlet syndrome.
    Thromb Res. 2022;213:65-70.
    >> Share

  141. BARBERO E, Manas E, Bikdeli B, Garcia-Ortega A, et al
    Untreated obstructive sleep apnea and cardiovascular outcomes in patients with acute symptomatic pulmonary embolism.
    Thromb Res. 2022;214:87-92.
    >> Share

  142. MONREAL M, Bertoletti L, Lopez-Nunez JJ, Tiberio G, et al
    TEMPORARY REMOVAL: OC-14: Effectiveness and safety of 6-months' treatment with different full-dose enoxaparin regimens in patients with cancer-associated venous thromboembolism: a subgroup analysis of the RIETECAT cohort study.
    Thromb Res. 2022;213 Suppl 2:S8-S9.
    >> Share

  143. BOSCH FTM, Campello E, Henderson MW, Mulder FI, et al
    TEMPORARY REMOVAL: OC-07: Contact pathway activation and risk of venous thromboembolism in patients with pancreatic cancer: the prospective SENECA study.
    Thromb Res. 2022;213 Suppl 2:S4.
    >> Share

  144. OVERVAD TF, Ording AG, Nielsen PB, Piazza G, et al
    TEMPORARY REMOVAL: OC-08: The Khorana score and risk of venous thromboembolism in patients with cancer treated with immune checkpoint inhibitors.
    Thromb Res. 2022;213 Suppl 2:S4-S5.
    >> Share

  145. ANTONUCCI E, Barcella L, Russo L, Chistolini A, et al
    TEMPORARY REMOVAL: PO-58: Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry.
    Thromb Res. 2022;213 Suppl 2:S39.
    >> Share

  146. MARTIN AM, Lecumberri R, Souto JC, Aparicio J, et al
    TEMPORARY REMOVAL: PO-57: Venous thromboembolism recurrence during anticoagulant treatment in gastrointestinal cancer patients.
    Thromb Res. 2022;213 Suppl 2:S38-S39.
    >> Share

  147. LOPEZ-NUNEZ JJ, Trujillo-Santos J, Bertoletti L, Lobo JL, et al
    TEMPORARY REMOVAL: PO-55: Effectiveness and safety of enoxaparin in the extended treatment of venous thromboembolism in active cancer patients with renal impairment: results from the RIETECAT-RI cohort study.
    Thromb Res. 2022;213 Suppl 2:S37-S38.
    >> Share

  148. SALGADO M, Molina R, Vazquez EB, Martinez E, et al
    TEMPORARY REMOVAL: PO-54: Preliminary evaluation of venous thromboembolic risk in patients with colorectal cancer from the CARTAGO study.
    Thromb Res. 2022;213 Suppl 2:S36-S37.
    >> Share

  149. DONADINI MP, Squizzato A, Ferrazzi P, Maggioni S, et al
    TEMPORARY REMOVAL: PO-43: Pharmacological thromboprophylaxis to prevent venous thromboembolism in ambulatory patients with cancer undergoing antineoplastic drugs in real world clinical practice: a cohort study.
    Thromb Res. 2022;213 Suppl 2:S30-S31.
    >> Share

  150. ANIJS RJS, Chen Q, Lijfering WM, Cannegieter SC, et al
    TEMPORARY REMOVAL: OC-05: Thromboembolism after incident colorectal cancer in the Netherlands: incidence, predictors, and prognosis.
    Thromb Res. 2022;213 Suppl 2:S3.
    >> Share

  151. HAQUE F, Jawad N, Brzuszek A, Birk R, et al
    TEMPORARY REMOVAL: PO-37: A study of the evolution of radiological features of untreated small volume pulmonary embolism (PE) in cancer patients.
    Thromb Res. 2022;213 Suppl 2:S28.
    >> Share

  152. FORESTA A, Colacioppo P, Baviera M, Ojeda-Fernandez L, et al
    TEMPORARY REMOVAL: PO-36: The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer.
    Thromb Res. 2022;213 Suppl 2:S27-S28.
    >> Share

  153. DAGUENET E, Maison M, Tinquaut F, Giroux EA, et al
    TEMPORARY REMOVAL: PO-22: Rate of venous thromboembolism events in cancer patients treated by radiation therapy: the Radiation-Induced Thrombosis study.
    Thromb Res. 2022;213 Suppl 2:S21.
    >> Share

  154. ALBERTSEN IE, Lyhne NM, Larsen TB, Nielsen PB, et al
    TEMPORARY REMOVAL: PO-24: Incidence of venous thromboembolism following head and neck surgery stratified according to cancer: a Danish nation-wide cohort study.
    Thromb Res. 2022;213 Suppl 2:S21-S22.
    >> Share

  155. MORAN LO, Pesantez D, Vazquez EB, Garay DF, et al
    TEMPORARY REMOVAL: PO-20: Incidence of venous thromboembolism in patients with BRAF-mutated colorectal cancer.
    Thromb Res. 2022;213 Suppl 2:S20.
    >> Share

  156. GERVASO L, Laffi A, Meneses-Medina MI, Cella CA, et al
    TEMPORARY REMOVAL: PO-19: Venous and arterial thromboembolism in pancreatic neuroendocrine neoplasms.
    Thromb Res. 2022;213 Suppl 2:S19-S20.
    >> Share

  157. JORGENSEN H, Horvath-Puho E, Laugesen K, Braekkan S, et al
    TEMPORARY REMOVAL: PO-17: Socioeconomic position and the risk of occult cancer in venous thromboembolism.
    Thromb Res. 2022;213 Suppl 2:S18-S19.
    >> Share

  158. SILVA-CARDENAS DC, Pikabea-Diaz F, Zumarraga-Cuesta A, Lopez-Santillan M, et al
    TEMPORARY REMOVAL: PO-14: Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients.
    Thromb Res. 2022;213 Suppl 2:S17.
    >> Share

  159. CHARLES S, Chaudier A, Fatrara T, Daguenet E, et al
    TEMPORARY REMOVAL: PO-05: D-dimers cut off level to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma.
    Thromb Res. 2022;213 Suppl 2:S13.
    >> Share

  160. TROELSEN FS, Vago EK, Horvath-Puho E, van Es N, et al
    TEMPORARY REMOVAL: PO-01: KRAS mutation in colorectal cancer and risk of venous thromboembolism: a Danish population-based cohort study.
    Thromb Res. 2022;213 Suppl 2:S11.
    >> Share

  161. JAKOBSEN SS, Frokjaer JB, Fisker RV, Kristensen SR, et al
    TEMPORARY REMOVAL: PO-02: Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper GI cancer patients.
    Thromb Res. 2022;213 Suppl 2:S11-S12.
    >> Share

  162. RUIZ M, Martin AM, Font C, Castellon V, et al
    TEMPORARY REMOVAL: OC-01: Mortality impact of cancer-associated venous thromboembolism: final analysis from Oncothromb12-01 study.
    Thromb Res. 2022;213 Suppl 2:S1.
    >> Share

  163. MCCRAE KR, Swaidani S, Diaz-Montero CM, Khorana AA, et al
    Old is new again: emergence of thromboembolic complications in cancer patients on immunotherapy.
    Thromb Res. 2022;213.
    >> Share

  164. MOIK F, Ay C
    Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies.
    Thromb Res. 2022;213 Suppl 1:S58-S65.
    >> Share

  165. DELLUC A, Robin P
    (18)F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know?
    Thromb Res. 2022;213 Suppl 1:S42-S45.
    >> Share

  166. MANTHA S, Rak J
    Cancer genetic alterations and risk of venous thromboembolism.
    Thromb Res. 2022;213 Suppl 1:S29-S34.
    >> Share

  167. SANFILIPPO KM
    Venous thromboembolism and risk stratification in hematological malignancies.
    Thromb Res. 2022;213 Suppl 1:S16-S21.
    >> Share

    April 2022
  168. NOUMEGNI SR, Didier R, Mansourati V, Tromeur C, et al
    Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
    Thromb Res. 2022;214:93-105.
    >> Share

  169. LIND MM, Johansson M, Sjalander A, Johansson L, et al
    Incidence and risk factors of venous thromboembolism in men and women.
    Thromb Res. 2022;214:82-86.
    >> Share

  170. PORFIDIA A, Esposto G, Manzo C, Santini P, et al
    No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19.
    Thromb Res. 2022;214:44-46.
    >> Share

  171. RUSSO F, Cianfanelli L, Chieffo A, Galli M, et al
    Ultrasound-assisted thrombolysis in high and intermediate-high risk pulmonary embolism patients with contraindications to systemic thrombolysis: a retrospective multicentre experience.
    Thromb Res. 2022;214:40-43.
    >> Share

  172. CATELLA J, Bertoletti L, Moustafa F, Nieto JA, et al
    Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism.
    Thromb Res. 2022;214:29-36.
    >> Share

    March 2022
  173. ROBERTS LN, Navaratnam AV, Arya R, Briggs TWR, et al
    Venous thromboembolism in patients hospitalised with COVID-19 in England.
    Thromb Res. 2022;213:138-144.
    >> Share

  174. VAN DER VLEUTEN CJM, Zwerink LGJM, Klappe EM, de Jong EMGJ, et al
    Is there a place for prophylaxis with DOACs in Klippel-Trenaunay syndrome and other low-flow vascular malformations with intravascular coagulopathy and thromboembolic events?
    Thromb Res. 2022;213:30-33.
    >> Share

  175. BOVA C, Vigna E, Gentile M, Pignataro FS, et al
    Performance of the Bova score in predicting short-term all-cause mortality in patients with pulmonary embolism and normal blood pressure. A systematic review and meta-analysis.
    Thromb Res. 2022;213:43-46.
    >> Share

  176. ABUFARHANEH M, Pandya RK, Alkhaja A, Iansavichene A, et al
    Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.
    Thromb Res. 2022;213:47-56.
    >> Share

  177. PALARETI G, Bignamini AA, Urbanek T, Cini M, et al
    Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study.
    Thromb Res. 2022;211:140-146.
    >> Share

    February 2022
  178. ABRUZZO A, Gorantla V, Thomas SE
    Venous thromboembolic events in the setting of extracorporeal membrane oxygenation support in adults: A systematic review.
    Thromb Res. 2022;212:58-71.
    >> Share

  179. CATELLA J, Joly M, Pernod G
    Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?
    Thromb Res. 2022;213:8.
    >> Share

  180. VOCI D, Fedeli U, Farmakis IT, Hobohm L, et al
    Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area.
    Thromb Res. 2022;212:44-50.
    >> Share

  181. DANIELSBACKA JS, Mannerkorpi K, Olsen MF
    Health care professionals' conceptions of respiratory symptoms and physical activity in patients with acute pulmonary embolism. A phenomenographic interview study.
    Thromb Res. 2022;212:22-29.
    >> Share

  182. BONNESEN K, Heide-Jorgensen U, Albertsen LW, Schmidt SAJ, et al
    Validation of the Danish Comorbidity Index for Acute Myocardial Infarction for predicting one-year mortality in patients with venous thromboembolism.
    Thromb Res. 2022;212:9-18.
    >> Share

  183. TZOUMAS A, Peppas S, Sagris M, Papanastasiou CA, et al
    Advances in treatment of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2022;212:30-37.
    >> Share

  184. BEAUDOIN E, Kaka S, Gagnon E, Durivage A, et al
    Use of D-dimer for the exclusion of new pulmonary embolism in anticoagulated patients: A multicenter retrospective study.
    Thromb Res. 2022;212:19-21.
    >> Share

  185. BETENSKY M, Kumar R, Hankins JS, Goldenberg NA, et al
    Venous thromboembolism in pediatric patients with sickle cell disease: A north American survey on experience and management approaches of pediatric hematologists.
    Thromb Res. 2022;211:133-139.
    >> Share

  186. KALAITZOPOULOS DR, Panagopoulos A, Samant S, Ghalib N, et al
    Management of venous thromboembolism in pregnancy.
    Thromb Res. 2022;211:106-113.
    >> Share

    January 2022
  187. KALAYCI A, Gibson CM, Hernandez AF, Hull RD, et al
    Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial.
    Thromb Res. 2022;211:63-69.
    >> Share

  188. SHEN Y, Zhang Y, Xiong Y, Zhang Z, et al
    Whole exome sequencing identifies genetic variants in Chinese Han pregnant women with venous thromboembolism.
    Thromb Res. 2022;211:49-55.
    >> Share

  189. POHL KR, Hobohm L, Krieg VJ, Sentler C, et al
    Impact of thyroid dysfunction on short-term outcomes and long-term mortality in patients with pulmonary embolism.
    Thromb Res. 2022;211:70-78.
    >> Share

  190. CABALLERO-ERASO C, Lopez-Ramirez C, Marin-Romero S, Carrera-Cueva C, et al
    Venous thromboembolism in amyotrophic lateral sclerosis. A prospective quasi-experimental study.
    Thromb Res. 2022;211:81-84.
    >> Share

  191. BIKDELI B, Moustafa F, Nieto JA, Lee AI, et al
    Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism.
    Thromb Res. 2022;211:10-18.
    >> Share

    December 2021
  192. PETRELLI F, Cabiddu M, Borgonovo K, Parati MC, et al
    Osimertinib-related venous thromboembolism in non small lung cancer.
    Thromb Res. 2021;210:63-66.
    >> Share

  193. SIMARD C, Malhame I, Skeith L, Carson MP, et al
    Management of anticoagulation in pregnant women with venous thromboembolism: An international survey of clinical practice.
    Thromb Res. 2021;210:20-25.
    >> Share

  194. WANG L, Wei S, Zhou B, Wu S, et al
    Corrigendum to "A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors" [Thromb. Res. 202, June 2021, 52-58].
    Thromb Res. 2021;210:4-5.
    >> Share

  195. SONNE-HOLM E, Kjaergaard J, Bang LE, Fosbol E, et al
    Pulmonary embolism: Age specific temporal trends in incidence and mortality in Denmark 1999-2018.
    Thromb Res. 2021;210:12-19.
    >> Share

  196. ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
    Corrigendum to "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE" [Thromb. Res. 2021 May;201:63-72].
    Thromb Res. 2021;209:105.
    >> Share

  197. ZUIN M, Engelen MM, Barco S, Spyropoulos AC, et al
    Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis.
    Thromb Res. 2021;209:94-98.
    >> Share

  198. DE WINTER MA, Timmers T, Hovens MMC, Iglesias Del Sol A, et al
    Effect of an interactive, educational app about venous thromboembolism and anticoagulation on patient satisfaction: A randomized controlled trial.
    Thromb Res. 2021;209:86-93.
    >> Share

  199. BOUNAMEAUX H, Haas S, Farjat AE, Ageno W, et al
    Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112].
    Thromb Res. 2021 Dec 1. pii: S0049-3848(21)00545.
    >> Share

    November 2021
  200. VERMA AA, Masoom H, Pou-Prom C, Shin S, et al
    Developing and validating natural language processing algorithms for radiology reports compared to ICD-10 codes for identifying venous thromboembolism in hospitalized medical patients.
    Thromb Res. 2021;209:51-58.
    >> Share

  201. BOLZACCHINI E, Pomero F, Fazio M, Civitelli C, et al
    Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.
    Thromb Res. 2021;208:190-197.
    >> Share

  202. ZUIN M, Cervellati C, Rigatelli G, Zuliani G, et al
    Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
    Thromb Res. 2021;208:170-172.
    >> Share

  203. GIRAUD M, Catella J, Cognet L, Helfer H, et al
    Management of acute venous thromboembolism in patients taking antiplatelet therapy.
    Thromb Res. 2021;208:156-161.
    >> Share

  204. GUPTA A, Chegondi M, Billa RD, Bloxham J, et al
    Validation of risk assessment models for venous thromboembolism and bleeding in critically ill adolescents.
    Thromb Res. 2021;208:106-111.
    >> Share

  205. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
    Thromb Res. 2021 Nov 3. pii: S0049-3848(21)00492.
    >> Share

    October 2021
  206. LEE A, Oley F Jr, Lo M, Fong R, et al
    Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors.
    Thromb Res. 2021;208:148-155.
    >> Share

  207. NAYAK AL, Zahrai A, Mallick R, Wang TF, et al
    Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial.
    Thromb Res. 2021;208:79-82.
    >> Share

  208. HILL H, Robinson M, Lu L, Slaughter D, et al
    Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
    Thromb Res. 2021;208:71-78.
    >> Share

  209. HANSEN ES, Rinde FB, Edvardsen MS, Hindberg K, et al
    Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
    Thromb Res. 2021;208:121-126.
    >> Share

  210. LI A, Brandt W, Brown C, Wang TF, et al
    Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis.
    Thromb Res. 2021;208:58-65.
    >> Share

  211. HAZELTINE MD, Guber RD, Buettner H, Dorfman JD, et al
    Venous thromboembolism risk stratification in trauma using the Caprini risk assessment model.
    Thromb Res. 2021;208:52-57.
    >> Share

  212. LI J, Yi J, Hua L, Su Y, et al
    Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.
    Thromb Res. 2021;208:45-51.
    >> Share

  213. BALLERIE A, Nguyen Van R, Lacut K, Galinat H, et al
    Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes.
    Thromb Res. 2021;208:39-44.
    >> Share

  214. DOUILLET D, Riou J, Penaloza A, Moumneh T, et al
    Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts.
    Thromb Res. 2021;208:4-10.
    >> Share

  215. PASHA AK, McBane RD, Chaudhary R, Padrnos LJ, et al
    Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19.
    Thromb Res. 2021;207:150-157.
    >> Share

  216. BOON GJAM, Janssen SMJ, Barco S, Bogaard HJ, et al
    Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome.
    Thromb Res. 2021;206:66-75.
    >> Share

    September 2021
  217. TCHAIKOVSKI SN, Thomassen MCLGD, Stickeler E, Bremme K, et al
    Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism.
    Thromb Res. 2021;207:143-149.
    >> Share

  218. LUU IHY, Kroon FPB, Buijs J, Krdzalic J, et al
    Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department.
    Thromb Res. 2021;207:113-115.
    >> Share

  219. MARTIN AM, Polistena P, Mahmud A, Bettridge B, et al
    Optimal enoxaparin dosing strategies for venous thromboembolism prophylaxis and treatment of high body weight patients.
    Thromb Res. 2021;207:116-122.
    >> Share

  220. GABET A, Grave C, Tuppin P, Emmerich J, et al
    Changes in the epidemiology of patients hospitalized in France with deep venous thrombosis and pulmonary embolism during the COVID-19 pandemic.
    Thromb Res. 2021;207:67-74.
    >> Share

  221. OHASHI Y, Ikeda M, Kunitoh H, Sasako M, et al
    One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry.
    Thromb Res. 2021 Sep 21. pii: S0049-3848(21)00464.
    >> Share

  222. OAKES M, Arastu A, Kato C, Somers J, et al
    Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.
    Thromb Res. 2021;207:96-98.
    >> Share

    August 2021
  223. STESSEL B, Peeters J, Bruckers L, Nulens M, et al
    Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
    Thromb Res. 2021;206:139-141.
    >> Share

  224. HAKSTEEN WE, Hilderink BN, Dujardin RWG, Jansen RR, et al
    Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients.
    Thromb Res. 2021;206:128-130.
    >> Share

  225. YAMAURA G, Ito T, Miyaji Y, Ueda N, et al
    Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism.
    Thromb Res. 2021;206:99-103.
    >> Share

  226. WENGER N, Sebastian T, Engelberger RP, Kucher N, et al
    Pulmonary embolism and deep vein thrombosis: Similar but different.
    Thromb Res. 2021;206:88-98.
    >> Share

  227. JOHNSON SA, Jones AE, Young E, Jennings C, et al
    A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
    Thromb Res. 2021;206:120-127.
    >> Share

  228. FERNANDO SM, Mathew R, Munshi L, Siegal DM, et al
    Media portrayals of pulmonary embolism.
    Thromb Res. 2021;206:52-54.
    >> Share

  229. FILIPPI L, Sartori M, Facci M, Trentin M, et al
    Pulmonary embolism in patients with COVID-19 pneumonia: When we have to search for it?
    Thromb Res. 2021;206:29-32.
    >> Share

  230. HANNA-SAWIRES RG, Groen JV, Hamming A, Tollenaar RAEM, et al
    Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer.
    Thromb Res. 2021;207:134-139.
    >> Share

  231. KNOLL W, Fergusson N, Ivankovic V, Wang TF, et al
    Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature.
    Thromb Res. 2021;204:114-122.
    >> Share

    July 2021
  232. HOLSTEEN P, Meier M, Brennan L, VanHorn T, et al
    Safety and effectiveness of a risk-stratified venous thromboembolism prophylaxis algorithm in young people with cystic fibrosis.
    Thromb Res. 2021;206:36-41.
    >> Share

  233. GRANOT Y, Rozenbaum Z, Ziv-Baran T, Fares R, et al
    Correlation between CT-derived cardiac chamber volume, myocardial injury and mortality in acute pulmonary embolism.
    Thromb Res. 2021;205:63-69.
    >> Share

  234. DANIELSBACKA JS, Rostberg L, Olsen MF, Mannerkorpi K, et al
    "Whole life changed" - Experiences of how symptoms derived from acute pulmonary embolism affects life. A qualitative interview study.
    Thromb Res. 2021;205:56-62.
    >> Share

  235. LACHANT D, Roto D, Rappaport S, Prasad P, et al
    Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza.
    Thromb Res. 2021;205:40-43.
    >> Share

  236. METRA B, Summer R, Brooks SE, George G, et al
    Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study.
    Thromb Res. 2021;205:84-91.
    >> Share

  237. GAWLITZA J, Ziegelmayer S, Wilkens H, Jagoda P, et al
    Beyond the d-dimer - Machine-learning assisted pre-test probability evaluation in patients with suspected pulmonary embolism and elevated d-dimers.
    Thromb Res. 2021;205:11-16.
    >> Share

  238. COHEN AT, Maraveyas A, Beyer-Westendorf J, Lee AYY, et al
    Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study.
    Thromb Res. 2021;206:1-4.
    >> Share

  239. RIGATELLI G, Zuin M
    Not all patent foramen ovales are alike!
    Thromb Res. 2021;203:81.
    >> Share

  240. SKILLE H, Paulsen B, Hveem K, Severinsen MT, et al
    Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.
    Thromb Res. 2021;205:17-23.
    >> Share

    June 2021
  241. JIN MC, Sussman ES, Feng AY, Han SS, et al
    Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients.
    Thromb Res. 2021;204:126-133.
    >> Share

  242. RIVERA-LEBRON B, Bauersachs R
    Direct oral anticoagulants for the treatment of pulmonary embolism in patients with renal impairment.
    Thromb Res. 2021;204:101-107.
    >> Share

  243. KO D, Preis SR, Johnson AD, Vasan RS, et al
    Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism.
    Thromb Res. 2021;204:108-113.
    >> Share

  244. SANSILVESTRI-MOREL P, Rupin A, Schaffner AP, Bertin F, et al
    S62798, a potent TAFIa inhibitor, accelerates endogenous fibrinolysis in a murine model of pulmonary thromboembolism.
    Thromb Res. 2021;204:81-87.
    >> Share

  245. YAMASHITA Y, Bikdeli B, Monreal M, Morimoto T, et al
    Difference between Japanese and White patients with acute pulmonary embolism.
    Thromb Res. 2021;204:52-56.
    >> Share

  246. BAN L, Abdul Sultan A, West J, Tata LJ, et al
    External validation of a model to predict women most at risk of postpartum venous thromboembolism: Maternity clot risk.
    Thromb Res. 2021 Jun 8. pii: S0049-3848(21)00360.
    >> Share

  247. BLONDON M, Martinez de Tejada B, Glauser F, Righini M, et al
    Management of high-risk pulmonary embolism in pregnancy.
    Thromb Res. 2021;204:57-65.
    >> Share

  248. MENDONCA JC, Martins J, Fernandes C, Carvalho C, et al
    Cancer risk after a venous thrombotic event - RIETE score.
    Thromb Res. 2021;202:43-44.
    >> Share

  249. VALERIO L, Corsi G, Granziera S, Holm K, et al
    Sex differences in Lemierre syndrome: Individual patient-level analysis.
    Thromb Res. 2021;202:36-39.
    >> Share

    May 2021
  250. RAHBAR E, Cotton BA, Wade CE, Cardenas JC, et al
    Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma.
    Thromb Res. 2021;204:9-12.
    >> Share

  251. PAGENHARDT J, Hayward I, Dilcher B, Quedado K, et al
    Incidence of abnormal uterine bleeding in a multicenter implementation study using apixaban and rivaroxaban to treat venous thromboembolism.
    Thromb Res. 2021;204:29-31.
    >> Share

  252. LE MAO R, Tromeur C, Couturaud F
    A case of acute pulmonary embolism with severe haemoptysis.
    Thromb Res. 2021 May 18. pii: S0049-3848(21)00332.
    >> Share

  253. NOUMEGNI SR, Hoffmann C, Tromeur C, Lacut K, et al
    Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies.
    Thromb Res. 2021;203:172-185.
    >> Share

  254. GOTO S, Turpie AGG, Farjat AE, Weitz JI, et al
    The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.
    Thromb Res. 2021;203:155-162.
    >> Share

  255. BARATH B, Bogati R, Miklos T, Kallai J, et al
    Effect of alpha2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
    Thromb Res. 2021;203:110-116.
    >> Share

  256. ARRIBALZAGA K, Martinez-Alfonzo I, Diaz-Aizpun C, Gutierrez-Jomarron I, et al
    Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.
    Thromb Res. 2021;203:93-100.
    >> Share

  257. JOHNSON SA, Signor EA, Lappe KL, Shi J, et al
    A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism.
    Thromb Res. 2021;203:190-195.
    >> Share

  258. MUMOLI N, Conte G, Cei M, Vitale J, et al
    In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
    Thromb Res. 2021;203:82-84.
    >> Share

  259. BAKKUM MJ, Schouten VL, Smulders YM, Nossent EJ, et al
    Accelerated treatment with rtPA for pulmonary embolism induced circulatory arrest.
    Thromb Res. 2021;203:74-80.
    >> Share

  260. HAMER HM, Stroobants AK, Bavalia R, Ponjee GAE, et al
    Diagnostic accuracy of four different D-dimer assays: A post-hoc analysis of the YEARS study.
    Thromb Res. 2021;201:18-22.
    >> Share

    April 2021
  261. BAUMANN KREUZIGER L, Gaddh M, Onadeko O, George G, et al
    Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
    Thromb Res. 2021;202:155-161.
    >> Share

  262. KAPTEIN FHJ, Kroft LJM, Hammerschlag G, Ninaber MK, et al
    Pulmonary infarction in acute pulmonary embolism.
    Thromb Res. 2021;202:162-169.
    >> Share

  263. HUSSER D, Hohenstein S, Pellissier V, Konig S, et al
    Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic.
    Thromb Res. 2021;202:145-147.
    >> Share

    March 2021
  264. DOUROS A, Filliter C, Azoulay L, Tagalakis V, et al
    Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism.
    Thromb Res. 2021;202:128-133.
    >> Share

  265. YUAN S, Bruzelius M, Hakansson N, Akesson A, et al
    Lifestyle factors and venous thromboembolism in two cohort studies.
    Thromb Res. 2021;202:119-124.
    >> Share

  266. BRAILOVSKY Y, Masic D, Allen S, Lakhter V, et al
    Novel CT-derived parameter is associated with low cardiac index in acute pulmonary embolism.
    Thromb Res. 2021;202:105-107.
    >> Share

  267. SKEITH L, Le Gal G, Rodger MA
    Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
    Thromb Res. 2021;202:134-138.
    >> Share

  268. KIRCHBERGER I, Berghaus TM, von Scheidt W, Linseisen J, et al
    COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism.
    Thromb Res. 2021;202:77-83.
    >> Share

  269. ALLEN S, Chan L, Masic D, Porcaro K, et al
    Comparison of outcomes in catheter-directed versus ultrasound-assisted thrombolysis for management of submassive pulmonary embolism.
    Thromb Res. 2021;202:96-99.
    >> Share

  270. PETRELLI F, Solinas C
    Reply to the letter to the editor 'Reply to Solinas et al, venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review' by Frere et al.
    Thromb Res. 2021 Mar 11. pii: S0049-3848(21)00092.
    >> Share

  271. AKTAA S, Wu J, Nadarajah R, Rashid M, et al
    Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
    Thromb Res. 2021;202:17-23.
    >> Share

  272. LACUT K, Le Moigne E, Couturaud F, Font C, et al
    Outcomes in patients with acute pulmonary embolism and patent foramen ovale: Findings from the RIETE registry.
    Thromb Res. 2021;202:59-66.
    >> Share

  273. ARANDA C, Peralta L, Gagliardi L, Lopez A, et al
    A significant decrease in D-dimer concentration within one month of anticoagulation therapy as a predictor of both complete recanalization and risk of recurrence after initial pulmonary embolism.
    Thromb Res. 2021;202:31-35.
    >> Share

  274. FRERE C, Ederhy S, Salem JE
    Letter to the editors-in-chief reply to: Solinas et al. Venous and arterial thromboembolic events with immune check point inhibitors: A systematic review.
    Thromb Res. 2021 Mar 3. pii: S0049-3848(21)00083.
    >> Share

  275. WANG L, Wei S, Zhou B, Wu S, et al
    A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors.
    Thromb Res. 2021;202:52-58.
    >> Share

  276. KAPTEIN FHJ, Stals MAM, Grootenboers M, Braken SJE, et al
    Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.
    Thromb Res. 2021;199:143-148.
    >> Share

  277. ESENWA C, Unda SR, Altschul DJ, Patel NK, et al
    The effect of race on composite thrombotic events in patients with COVID-19.
    Thromb Res. 2021;199:10-13.
    >> Share

    February 2021
  278. WHYTE MB, Barker R, Kelly PA, Gonzalez E, et al
    Three-month follow-up of pulmonary embolism in patients with COVID-19.
    Thromb Res. 2021;201:113-115.
    >> Share

  279. GARCIA-ORTEGA A, Lopez-Reyes R, Anguera G, Oscullo G, et al
    Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.
    Thromb Res. 2021;201:131-138.
    >> Share

  280. ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
    Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE.
    Thromb Res. 2021;201:63-72.
    >> Share

  281. JERVAN O, Gleditsch J, Tavoly M, Klok FA, et al
    Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism.
    Thromb Res. 2021;201:90-99.
    >> Share

  282. SKAJAA N, Nagy D, Schonfeldt Troelsen F, Kormendine Farkas D, et al
    Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study.
    Thromb Res. 2021;201:1-5.
    >> Share

  283. MCFARLANE SQ, Patel JP, Auyeung V, Arya R, et al
    An international survey of low molecular weight heparin prescribing in the context of antenatal venous thromboembolism.
    Thromb Res. 2021;200:99-101.
    >> Share


  284. Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study.
    Thromb Res. 2021;200:130-132.
    >> Share

    January 2021
  285. STEIN PD, Matta F, Hughes PG, Gerstner BJ, et al
    Usefulness of ancillary findings on CT pulmonary angiograms that are negative for pulmonary embolism.
    Thromb Res. 2021;200:48-50.
    >> Share

  286. BECATTINI C, Cimini LA, Carrier M
    Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
    Thromb Res. 2021;200:41-47.
    >> Share

  287. BOIETTI B, Fili S, Peuchot V, Tabares A, et al
    Impact of the use of rivaroxaban in the length of stay of patients treated for acute venous thromboembolism in a developing country.
    Thromb Res. 2021 Jan 26. pii: S0049-3848(21)00030.
    >> Share

  288. PETERSEN PB, Lindberg-Larsen M, Jorgensen CC, Kehlet H, et al
    Venous thromboembolism after fast-track elective revision hip and knee arthroplasty - A multicentre cohort study of 2814 unselected consecutive procedures.
    Thromb Res. 2021;199:101-105.
    >> Share

  289. GANGARAJU R, Gahagan A, Bhatia S, Kenzik K, et al
    Venous-thromboembolism in elderly patients with acute myeloid leukemia.
    Thromb Res. 2021;200:9-11.
    >> Share

  290. DESANCHO M, Munn JE, Billett HH, Cheng D, et al
    Transition of care for pediatric and adult patients with venous thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN).
    Thromb Res. 2021;200:23-29.
    >> Share

  291. DE WINTER MA, van Es N, Buller HR, Visseren FLJ, et al
    Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
    Thromb Res. 2021;199:85-96.
    >> Share

  292. MURGIER M, Fouillet L, Ollier E, Merah A, et al
    Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study.
    Thromb Res. 2021;199:106-109.
    >> Share

  293. SINDET-PEDERSEN C, Olesen JB, Blanche P, Gerds TA, et al
    Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study.
    Thromb Res. 2021;199:97-100.
    >> Share

  294. AYELE HT, Brunetti VC, Renoux C, Tagalakis V, et al
    Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials.
    Thromb Res. 2021;199:123-131.
    >> Share

  295. MOIK F, Makatsariya A, Ay C
    Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management.
    Thromb Res. 2021;199:38-42.
    >> Share

  296. MANDAL AKJ, Kho J, Ioannou A, Van den Abbeele K, et al
    In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis.
    Thromb Res. 2021;197:112-113.
    >> Share

  297. PANCANI R, Villari L, Foci V, Parri G, et al
    Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units.
    Thromb Res. 2021;197:44-47.
    >> Share

    December 2020
  298. ACHEBE I, Mbachi C, Palacios P, Wang Y, et al
    Predictors of venous thromboembolism in hospitalized patients with inflammatory bowel disease and colon cancer: A retrospective cohort study.
    Thromb Res. 2020;199:14-18.
    >> Share

  299. ALAM AU, Karkhaneh M, Sun HL, Wu C, et al
    Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015.
    Thromb Res. 2020;199:59-66.
    >> Share

  300. NAUKA PC, Baron SW, Assa A, Mohrmann L, et al
    Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
    Thromb Res. 2020;199:82-84.
    >> Share

  301. VAN DAM LF, Kroft LJM, Boon GJAM, Huisman MV, et al
    Computed tomography pulmonary perfusion imaging and 3-months clinical outcomes after acute pulmonary embolism.
    Thromb Res. 2020;199:32-34.
    >> Share

  302. RASHIDI F, Barco S, Kamangar F, Heresi GA, et al
    Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.
    Thromb Res. 2020;198:135-138.
    >> Share

  303. GUO JD, Hlavacek P, Rosenblatt L, Keshishian A, et al
    Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.
    Thromb Res. 2020;198:163-170.
    >> Share

  304. DE WIT K, Linkins LA
    A case of acute pulmonary embolism in a patient with chronic thrombocytopenia.
    Thromb Res. 2020;198:83-85.
    >> Share

  305. MIAO R, Dong X, Gong J, Wang Y, et al
    Possible immune regulation mechanisms for the progression of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2020;198:122-131.
    >> Share

  306. ALHOUSANI M, Malik SU, Abu-Hashyeh A, Poznanski NJ, et al
    Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2020;198:103-114.
    >> Share

  307. WANG L, Chen F, Bai L, Yi Q, et al
    In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist.
    Thromb Res. 2020;196:541-542.
    >> Share

  308. PARKS AL, Auerbach AD, Schnipper JL, Anstey JE, et al
    COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
    Thromb Res. 2020;196:355-358.
    >> Share

    November 2020
  309. KANEDA K, Yamashita Y, Morimoto T, Amano H, et al
    Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
    Thromb Res. 2020;198:26-33.
    >> Share

  310. LI A, Eshaghpour A, Tseng EK, Douketis JD, et al
    Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more.
    Thromb Res. 2020;198:1-6.
    >> Share

  311. POLI D, Migliaccio L, Antonucci E, Biancone L, et al
    Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS.
    Thromb Res. 2020;198:52-54.
    >> Share

  312. SCUDIERO F, Silverio A, Di Maio M, Russo V, et al
    Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome.
    Thromb Res. 2020;198:34-39.
    >> Share

  313. STEINBRECHER O, Sinkovec H, Eischer L, Kyrle PA, et al
    D-dimer levels over time after anticoagulation and the association with recurrent venous thromboembolism.
    Thromb Res. 2020;197:160-164.
    >> Share

  314. BUDD AC, Rhodes M, Forster AJ, Noghani P, et al
    Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
    Thromb Res. 2020;197:144-152.
    >> Share

  315. PLANQUETTE B, Le Berre A, Khider L, Yannoutsos A, et al
    Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study.
    Thromb Res. 2020;197:94-99.
    >> Share

  316. ROBERGE G, Delluc A
    Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer.
    Thromb Res. 2020;197:77-83.
    >> Share

  317. ANDRADE I, Mehdipoor G, Le Mao R, Garcia-Sanchez A, et al
    Prognostic significance of computed tomography-assessed right ventricular enlargement in low-risk patients with pulmonary embolism: Systematic review and meta-analysis.
    Thromb Res. 2020;197:48-55.
    >> Share

  318. PAYNE JG, Tagalakis V, Wu C, Lazo-Langner A, et al
    Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis.
    Thromb Res. 2020;197:8-12.
    >> Share

  319. MARCHIORI E, Nobre LF, Hochhegger B, Zanetti G, et al
    The reversed halo sign: Considerations in the context of the COVID-19 pandemic.
    Thromb Res. 2020;195:228-230.
    >> Share

  320. ELIAS A, Schmidt J, Bellou A, Le Gal G, et al
    Opinion and practice survey about the use of prognostic models in acute pulmonary embolism.
    Thromb Res. 2020;198:40-48.
    >> Share

    October 2020
  321. SERRAO A, Ballotta L, Dragoni F, Pallotta A, et al
    Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia.
    Thromb Res. 2020;196:539-540.
    >> Share

  322. SPEED V, Patel JP, Roberts LN, Patel RK, et al
    UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry.
    Thromb Res. 2020;197:16-19.
    >> Share

  323. BRUGGEMANN RAG, Spaetgens B, Gietema HA, Brouns SHA, et al
    The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison.
    Thromb Res. 2020;196:486-490.
    >> Share

  324. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
    Thromb Res. 2020 Oct 13. pii: S0049-3848(20)30537.
    >> Share

  325. VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
    More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism.
    Thromb Res. 2020;196:435-436.
    >> Share

  326. HAN X, Li C, Zhang S, Hou X, et al
    Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.
    Thromb Res. 2020;196:500-509.
    >> Share

  327. VALERIO L, Corsi G, Sebastian T, Barco S, et al
    Lemierre syndrome: Current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry.
    Thromb Res. 2020;196:494-499.
    >> Share

  328. CHOPARD R, Badoz M, Eveno C, Ecarnot F, et al
    Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study.
    Thromb Res. 2020;196:476-482.
    >> Share

  329. GERSTEIN L, Koolian M, Schwartz BC
    Sub-segmental pulmonary emboli as a marker of CT-pulmonary angiogram overuse in a single-center retrospective cohort study: A dimer a dozen?
    Thromb Res. 2020;196:463-465.
    >> Share

  330. DOYLE AJ, Thomas W, Retter A, Besser M, et al
    Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units.
    Thromb Res. 2020;196:454-456.
    >> Share

  331. SOLINAS C, Saba L, Sganzerla P, Petrelli F, et al
    Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review.
    Thromb Res. 2020;196:444-453.
    >> Share

  332. RASMUSSEN PV, Blanche P, Strange JE, Butt JH, et al
    Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark.
    Thromb Res. 2020;194:220-221.
    >> Share

    September 2020
  333. YANG M, Qi J, Tang Y, Wu D, et al
    Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2020;196:410-413.
    >> Share

  334. MA SG, Hu J, Huang Y
    The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: A meta-analysis.
    Thromb Res. 2020;196:325-334.
    >> Share

  335. CHOI JJ, Wehmeyer GT, Li HA, Alshak MN, et al
    D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.
    Thromb Res. 2020;196:318-321.
    >> Share

  336. CASTELLON RUBIO VE, Segura PP, Munoz A, Farre AL, et al
    High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
    Thromb Res. 2020;196:349-354.
    >> Share

  337. DUJARDIN RWG, Hilderink BN, Haksteen WE, Middeldorp S, et al
    Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Thromb Res. 2020;196:308-312.
    >> Share

  338. PAVONI V, Gianesello L, Pazzi M, Stera C, et al
    Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Thromb Res. 2020;196:313-317.
    >> Share

  339. DELATE T, Charlu M, Zhu S, Pai A, et al
    Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism.
    Thromb Res. 2020;196:367-370.
    >> Share

  340. MIRO O, Llorens P, Aguirre A, Lozano L, et al
    Association between Covid-19 and Pulmonary Embolism (AC-19-PE study).
    Thromb Res. 2020;196:322-324.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016